MP18-17 KNOCKDOWN OF PD-L1 IN MOUSE RENAL CELL CARCINOMA INHIBITS TUMOR GROWTH AND IMPROVE THE ANTI-TUMOR EFFECT OF SUNITINIB

2020 
INTRODUCTION AND OBJECTIVE:There are several unresolved issues regarding combined treatment with an immune checkpoint inhibitor and anti-angiogenic agent for renal cell carcinoma (RCC) patients. Th...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []